 Transfusion-associated graft-vs-host disease patients malignancies Report cases review literature Graft-vs-host disease immunosuppressed individuals blood-product transfusions immunocompetent lymphocytes cases fatal transfusion-associated graft-vs-host disease patients Hodgkin disease therapy cases entity patients malignancies patients hematologic malignancies groups risk development transfusion-associated graft-vs-host disease clinical presentation course methods diagnosis Prevention fatal condition possible irradiation blood products patients risk problems groups measures Dermatologists awareness entity complete diagnosis establishment effective standards care